Quantitative somatostatin receptor image assessment for survival prediction: a full-body, longitudinal, individual lesion analysis of neuroendocrine tumors in patients treated with peptide receptor radiation therapy

被引：0
|
作者：
Santoro-Fernandes, V. [1 ]
Schott, B. [1 ]
Deatsch, A. [1 ]
Keigley, Q. [2 ]
Francken, T. [1 ]
Meeker, R. [1 ]
Lyer, R. [3 ]
Christos, F. [3 ]
Perlman, S. [2 ,4 ]
Jeraj, R. [1 ,4 ]
机构：
[1] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Wisconsin, Sect Nucl Med & Mol Imaging, Dept Radiol, Sch Med & Publ Hlth, Madison, WI USA
[3] Roswell Pk Comprehens Canc Ctr, Div GI Med, Dept Med, Buffalo, NY USA
[4] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-676
引用
收藏
页码：S314 / S315
页数：2
相关论文
共 50 条
  • [1] Tolerability and outcomes of neuroendocrine tumors treated with peptide receptor radionuclide therapy and stereotactic body radiation therapy
    Nunez, Rodriguez J.
    Ng, S.
    Chen, H.
    Singh, S.
    Hallet, J.
    Law, C.
    Myrehaug, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 186 - 186
  • [2] Quantitative digital image analysis of somatostatin receptor 2 immunohistochemistry in pancreatic neuroendocrine tumors
    Hirofumi Watanabe
    Rioko Ide
    Yuto Yamazaki
    Fumiyoshi Fujishima
    Atsuko Kasajima
    Samaneh Yazdani
    Tomoyoshi Tachibana
    Fuyuhiko Motoi
    Michiaki Unno
    Hironobu Sasano
    Medical Molecular Morphology, 2021, 54 : 324 - 336
  • [3] Quantitative digital image analysis of somatostatin receptor 2 immunohistochemistry in pancreatic neuroendocrine tumors
    Watanabe, Hirofumi
    Ide, Rioko
    Yamazaki, Yuto
    Fujishima, Fumiyoshi
    Kasajima, Atsuko
    Yazdani, Samaneh
    Tachibana, Tomoyoshi
    Motoi, Fuyuhiko
    Unno, Michiaki
    Sasano, Hironobu
    MEDICAL MOLECULAR MORPHOLOGY, 2021, 54 (04) : 324 - 336
  • [4] Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment
    Hamiditabar, Mohammadali
    Ali, Muzammil
    Roys, Joseph
    Wolin, Edward M.
    O'Dorisio, Thomas M.
    Ranganathan, David
    Tworowska, Izabela
    Strosberg, Jonathan R.
    Delpassand, Ebrahim S.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 436 - 443
  • [5] Quality Of Life in Patients with Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy
    Wang, Q.
    Librizzi, D.
    Bagheri, S.
    Ebrahimifard, A.
    Luster, M.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S246 - S247
  • [6] Predictors of survival in patients with neuroendocrine tumors after first full treatment cycle with peptide receptor radionuclide therapy
    Rodrigues, M.
    Nilica, B.
    Buxbaum, S.
    Uprimny, C.
    Gamper, E.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S212 - S212
  • [7] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [8] Quality Of Life in Patients with Neuroendocrine Gastroenteropancreatic Tumors Treated with Peptide Receptor Radionuclide Therapy
    Georgakopoulos, A.
    Liotsou, T.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S691 - S691
  • [9] Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
    Vukomanovic, Vladimir
    Nedic, Katarina Vuleta
    Radojevic, Marija Zivkovic
    Dagovic, Aleksandar
    Milosavljevic, Neda
    Markovic, Marina
    Ignjatovic, Vladimir
    Vukomanovic, Ivana Simic
    Djukic, Svetlana
    Sreckovic, Marijana
    Backovic, Milena
    Vuleta, Marko
    Djukic, Aleksandar
    Vukicevic, Verica
    Ignjatovic, Vesna
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [10] Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Kipnis, Sarit T.
    Hung, Matthew
    Kumar, Shria
    Heckert, Jason M.
    Lee, Hwan
    Bennett, Bonita
    Soulen, Michael C.
    Pryma, Daniel A.
    Mankoff, David A.
    Metz, David C.
    Eads, Jennifer R.
    Katona, Bryson W.
    JAMA NETWORK OPEN, 2021, 4 (03)
12345